AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11061523 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (dex; 4 mg, iv) with OT infusion in obese subjects
Number of subjects: 19
Study 9117220 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral microwave thermotherapy (TUMT)
Number of subjects: 120
Study 9117220 — intervention group
Group type: COMPARATOR
Intervention: Simulated treatment (placebo-like)
Number of subjects: 120
Study 9117220 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 120
Study 8450101 — intervention group
Group type: EXPERIMENTAL
Intervention: High-information preparation condition
Number of subjects: 72
Study 8450101 — intervention group
Group type: COMPARATOR
Intervention: Low-information preparation condition
Number of subjects: 72
Study 2439799 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol (BPL) 20 mg
Number of subjects: 8
Study 2439799 — intervention group
Group type: COMPARATOR
Intervention: Atenolol (ATL) 100 mg
Number of subjects: 8
Study 2701823 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG biofeedback treatment
Number of subjects: 40
Study 2701823 — intervention group
Group type: COMPARATOR
Intervention: Control treatment (routine physiotherapy)
Number of subjects: 40
Study 31562572 — intervention group
Group type: EXPERIMENTAL
Intervention: Sheroes (n=39)
Number of subjects: 77
Study 31562572 — intervention group
Group type: COMPARATOR
Intervention: Control (n=38)
Number of subjects: 77
Study 31164168 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily electronic patient-reported outcome (PRO) diaries
Number of subjects: 0
Study 27778463 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual field assessment
Number of subjects: 249
Study 27778463 — intervention group
Group type: COMPARATOR
Intervention: Optic disc photography
Number of subjects: 249
Study 26398071 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin
Number of subjects: 900
Study 26398071 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene
Number of subjects: 900
Study 26398071 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 900
Study 26398071 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 900
Study 23744329 — intervention group
Group type: EXPERIMENTAL
Intervention: SNP rs45514798 in MK2 gene
Number of subjects: 930
Study 23744329 — intervention group
Group type: COMPARATOR
Intervention: ZFP36 gene polymorphisms
Number of subjects: 930
Study 21423758 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF (10 µg/kg BW)
Number of subjects: 10
Study 21423758 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF
Number of subjects: 10
Study 21423758 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 18248549 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer coaches conducting AIDS education within sport (with mastery coaching strategies)
Number of subjects: 764
Study 18248549 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer coaches conducting AIDS education within sport (without mastery coaching strategies)
Number of subjects: 764
Study 18248549 — intervention group
Group type: COMPARATOR
Intervention: Traditional in-school AIDS education
Number of subjects: 764
Study 18248549 — intervention group
Group type: COMPARATOR
Intervention: No education (out-of-school children)
Number of subjects: 764
Study 17490568 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid resuscitation (250 ml bolus every 15 minutes until ITBVI>850 ml/m(2))
Number of subjects: 20
Study 17490568 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid resuscitation
Number of subjects: 20
Study 15505442 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 6
Study 15505442 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 6
Study 15505442 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 6
Study 15505442 — intervention group
Group type: COMPARATOR
Intervention: Recovery from Remifentanil
Number of subjects: 6
Study 11448424 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial recombinant fibroblast growth factor-2
Number of subjects: 0
Study 11448424 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9720857 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy
Number of subjects: 60
Study 9720857 — intervention group
Group type: COMPARATOR
Intervention: Control group (Relaxation)
Number of subjects: 60
Study 7986708 — intervention group
Group type: EXPERIMENTAL
Intervention: EPO 150 U/kg
Number of subjects: 71
Study 7986708 — intervention group
Group type: EXPERIMENTAL
Intervention: EPO 300 U/kg
Number of subjects: 71
Study 7986708 — intervention group
Group type: EXPERIMENTAL
Intervention: EPO 600 U/kg
Number of subjects: 71
Study 7986708 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 2688147 — intervention group
Group type: EXPERIMENTAL
Intervention: 200‐mg of enoxacin twice a day for two days
Number of subjects: 51
Study 2688147 — intervention group
Group type: EXPERIMENTAL
Intervention: 400‐mg of enoxacin twice a day for two days
Number of subjects: 51
Study 1137386 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin
Number of subjects: 0
Study 1137386 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin C(1)
Number of subjects: 0
Study 1137386 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin and Gentamicin C(1)
Number of subjects: 0
Study 31496653 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 70
Study 31496653 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 70
Study 31496653 — intervention group
Group type: COMPARATOR
Intervention: Normal Controls (NCs)
Number of subjects: 70
Study 29282152 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (50% maximum inspiratory pressure, twice daily for 4 weeks)
Number of subjects: 65
Study 29282152 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training
Number of subjects: 65
Study 29282152 — intervention group
Group type: COMPARATOR
Intervention: Sham inspiratory muscle training
Number of subjects: 65
Study 26248140 — intervention group
Group type: EXPERIMENTAL
Intervention: Online cognitive training platform
Number of subjects: 80
Study 26248140 — intervention group
Group type: COMPARATOR
Intervention: Communication or assistive features
Number of subjects: 80
Study 23769263 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic compression (IC) group (n=24)
Number of subjects: 117
Study 23769263 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive stretching group (n=23)
Number of subjects: 117
Study 23769263 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle energy technique group (n=23)
Number of subjects: 117
Study 23769263 — intervention group
Group type: COMPARATOR
Intervention: Wait-and-see group (n=25)
Number of subjects: 117
Study 23769263 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (n=22)
Number of subjects: 117
Study 21521911 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceram X (Nano Ceramic restorative material)
Number of subjects: 60
Study 21521911 — intervention group
Group type: EXPERIMENTAL
Intervention: Admira (Ormocer‐based composite)
Number of subjects: 60
Study 21521911 — intervention group
Group type: COMPARATOR
Intervention: Beautifil (Giomer)
Number of subjects: 60
Study 21521911 — intervention group
Group type: COMPARATOR
Intervention: Fuji IX (Glass ionomer cement)
Number of subjects: 60
Study 19254979 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose analgesia
Number of subjects: 240
Study 19254979 — intervention group
Group type: COMPARATOR
Intervention: Placebo water
Number of subjects: 240
Study 17109337 — intervention group
Group type: EXPERIMENTAL
Intervention: AIDSVAX B/E (VaxGen) vaccine
Number of subjects: 2546
Study 17109337 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2546
Study 15009462 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methionine load
Number of subjects: 20
Study 15009462 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 11571437 — intervention group
Group type: EXPERIMENTAL
Intervention: SRL-CsA-ST
Number of subjects: 525
Study 11571437 — intervention group
Group type: COMPARATOR
Intervention: SRL-ST
Number of subjects: 525
Study 9669720 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed formula (PHF)
Number of subjects: 22
Study 9669720 — intervention group
Group type: COMPARATOR
Intervention: Conventional formula (F)
Number of subjects: 22
Study 7848545 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti-inflammatory drugs (NSAIDs)
Number of subjects: 0
Study 7848545 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 0
Study 7848545 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular glucocorticosteroid therapy
Number of subjects: 0
Study 7848545 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral steroids and corticotrophin (adrenocorticotrophic hormone)
Number of subjects: 0
Study 7848545 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose colchicine
Number of subjects: 0
Study 7848545 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 0
Study 7848545 — intervention group
Group type: EXPERIMENTAL
Intervention: Uricosuric agents (e.g., probenecid)
Number of subjects: 0
Study 3273865 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefadroxil 30 mg/kg every 24 hours orally for ten days
Number of subjects: 32
Study 3273865 — intervention group
Group type: COMPARATOR
Intervention: Penicillin V potassium 15 mg/kg every eight hours orally for ten days
Number of subjects: 32
Study 3273865 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefadroxil
Number of subjects: 32
Study 3273865 — intervention group
Group type: COMPARATOR
Intervention: Penicillin
Number of subjects: 32
Study 3273865 — intervention group
Group type: EXPERIMENTAL
Intervention: Both therapies
Number of subjects: 32
Study 30085287 — intervention group
Group type: EXPERIMENTAL
Intervention: Small media intervention (SMI)
Number of subjects: 804
Study 30085287 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SMI)
Number of subjects: 804
Study 27810132 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioguided seed localization (RSL)
Number of subjects: 298
Study 27810132 — intervention group
Group type: COMPARATOR
Intervention: Wire localization (WL)
Number of subjects: 298
Study 25979552 — intervention group
Group type: EXPERIMENTAL
Intervention: Subscapularis-sparing TSA
Number of subjects: 96
Study 25979552 — intervention group
Group type: COMPARATOR
Intervention: Traditional TSA
Number of subjects: 96
Study 25166440 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase I periodontal treatment + NSAID (20 mg tenoxicam tablet once daily for 10 days)
Number of subjects: 32
Study 25166440 — intervention group
Group type: COMPARATOR
Intervention: Phase I periodontal treatment + placebo
Number of subjects: 32
Study 25166440 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (NSAID and placebo)
Number of subjects: 32
Study 22596383 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 7278
Study 22596383 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 7278
Study 22596383 — intervention group
Group type: EXPERIMENTAL
Intervention: Any intervention
Number of subjects: 7278
Study 19660009 — intervention group
Group type: EXPERIMENTAL
Intervention: NVP 200 mg b.i.d. plus > or =2 NRTIs and DRV/r 300/100 mg b.i.d.
Number of subjects: 19
Study 19660009 — intervention group
Group type: EXPERIMENTAL
Intervention: NVP 200 mg b.i.d. plus > or =2 NRTIs and DRV/r 400/100 mg b.i.d.
Number of subjects: 19
Study 19660009 — intervention group
Group type: COMPARATOR
Intervention: NVP 200 mg b.i.d. plus > or =2 NRTIs
Number of subjects: 19
Study 17454668 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysfunctional Attitude Scale: Form A (DAS‐A)
Number of subjects: 193
Study 17454668 — intervention group
Group type: EXPERIMENTAL
Intervention: Young Schema Questionnaire (YSQ)
Number of subjects: 193
Study 15088722 — intervention group
Group type: EXPERIMENTAL
Intervention: IPS Empress (pressable ceramic)
Number of subjects: 35
Study 15088722 — intervention group
Group type: EXPERIMENTAL
Intervention: Duceram (sintered ceramic)
Number of subjects: 35
Study 15088722 — intervention group
Group type: COMPARATOR
Intervention: Both IPS and Duceram
Number of subjects: 35
Study 11506759 — intervention group
Group type: EXPERIMENTAL
Intervention: Teledermatology consultation
Number of subjects: 229
Study 11506759 — intervention group
Group type: COMPARATOR
Intervention: Conventional hospital consultation
Number of subjects: 229
Study 11506759 — intervention group
Group type: COMPARATOR
Intervention: Conventional hospital appointment
Number of subjects: 229
Study 11506759 — intervention group
Group type: EXPERIMENTAL
Intervention: Teledermatology
Number of subjects: 229
Study 9626901 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of Mg orally per day for 1 month
Number of subjects: 16
Study 9626901 — intervention group
Group type: COMPARATOR
Intervention: No Mg (control group)
Number of subjects: 16
Study 7833230 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole (60 mg day-1)
Number of subjects: 24
Study 7833230 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 3046631 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilevalol (100 mg to 800 mg)
Number of subjects: 128
Study 3046631 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilevalol (200 mg)
Number of subjects: 128
Study 3046631 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 30795811 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component smoking cessation service package (regular motivation by nurse, monthly piCO+ Smokerlyzer test, assistance from trained family member, optional nicotine replacement gum)
Number of subjects: 319
Study 30795811 — intervention group
Group type: COMPARATOR
Intervention: Routine service (brief counseling and casual follow-up)
Number of subjects: 319
Study 27166622 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses group (n = 147)
Number of subjects: 298
Study 27166622 — intervention group
Group type: COMPARATOR
Intervention: Nurses + physician group (n = 151)
Number of subjects: 298
Study 25517581 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlus-o-Guide
Number of subjects: 20
Study 25517581 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study 22526703 — intervention group
Group type: EXPERIMENTAL
Intervention: Modic changes type I at both baseline and 14-month follow-up
Number of subjects: 0
Study 22526703 — intervention group
Group type: EXPERIMENTAL
Intervention: Modic changes size
Number of subjects: 0
Study 22526703 — intervention group
Group type: EXPERIMENTAL
Intervention: Modic changes developmental path
Number of subjects: 0
Study 20868965 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (4 μg/kg IV)
Number of subjects: 47
Study 18441042 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 minutes of daily training in sit‐to‐stand and leg strengthening exercises for 30 minutes, on weekdays for two weeks, with a physiotherapy assistant
Number of subjects: 18
Study 18441042 — intervention group
Group type: COMPARATOR
Intervention: Control group received arm therapy
Number of subjects: 18
Study 18441042 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 minutes of daily training in sit‐to‐stand
Number of subjects: 18
Study 15876493 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anaesthetic solution with morphine (1 mg)
Number of subjects: 60
Study 15876493 — intervention group
Group type: COMPARATOR
Intervention: Standard local anaesthetic solution (articaine plus epinephrine)
Number of subjects: 60
Study 15876493 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 12795735 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational sessions with medical residents (first intervention)
Number of subjects: 813
Study 12795735 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational sessions with medical residents (first intervention) and letters from the new doctor (second intervention)
Number of subjects: 813
Study 10371919 — intervention group
Group type: EXPERIMENTAL
Intervention: One randomly selected implant per patient
Number of subjects: 487
Study 10371919 — intervention group
Group type: COMPARATOR
Intervention: Entire material of 1,738 implants
Number of subjects: 487
Study 8676228 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (1 mg/kg) alone
Number of subjects: 100
Study 8676228 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.35 mg/kg) and ketamine (5 mg/kg)
Number of subjects: 100
Study 8475801 — intervention group
Group type: EXPERIMENTAL
Intervention: Fusidic acid
Number of subjects: 13
Study 3963025 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen 100 mg per day
Number of subjects: 35
Study 3963025 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen 150 mg per day
Number of subjects: 35
Study 3963025 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen 200 mg per day
Number of subjects: 35
Study 3963025 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 2600 mg per day
Number of subjects: 35
Study 3963025 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen (all doses)
Number of subjects: 35
Study 31634871 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger (1 gr orally before and after anesthesia)
Number of subjects: 92
Study 31634871 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine (25 mg slowly injected before surgery)
Number of subjects: 92
Study 30170894 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtered-sunlight phototherapy (FSPT)
Number of subjects: 174
Study 30170894 — intervention group
Group type: COMPARATOR
Intervention: Intensive electric phototherapy (IEPT)
Number of subjects: 174
Study 25318186 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal injection of pegaptanib sodium
Number of subjects: 243
Study 25318186 — intervention group
Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 243
Study 25318186 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegaptanib sodium
Number of subjects: 243
Study 25318186 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 243
Study 22458638 — intervention group
Group type: EXPERIMENTAL
Intervention: Active pindolol 20 mg retard daily
Number of subjects: 0
Study 22458638 — intervention group
Group type: COMPARATOR
Intervention: Placebo pindolol
Number of subjects: 0
Study 21330799 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fidelity glass globe model training
Number of subjects: 32
Study 21330799 — intervention group
Group type: COMPARATOR
Intervention: Control group (UM training only)
Number of subjects: 32
Study 17493762 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprathel
Number of subjects: 22
Study 17493762 — intervention group
Group type: COMPARATOR
Intervention: Jelonet
Number of subjects: 22
Study 15625220 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment Initiation Program (TIP)
Number of subjects: 0
Study 15625220 — intervention group
Group type: COMPARATOR
Intervention: Usual care (pharmacotherapy alone)
Number of subjects: 0
Study 11879130 — intervention group
Group type: EXPERIMENTAL
Intervention: Patching (initially treated for 6 hours per day or full-time patching)
Number of subjects: 409
Study 11879130 — intervention group
Group type: COMPARATOR
Intervention: Atropine (not detailed in the abstract)
Number of subjects: 409
Study 11879130 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual acuity in amblyopic eyes
Number of subjects: 409
Study 11879130 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual acuity in sound eyes
Number of subjects: 409
Study 10401689 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncorrected cyanotic CHD
Number of subjects: 41
Study 10401689 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrective surgery for cyanotic CHD
Number of subjects: 41
Study 10401689 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 41
Study 10401689 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-surgery cyanotic CHD (2 years after surgery)
Number of subjects: 41
Study 10401689 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyanotic CHD
Number of subjects: 41
Study 7645695 — intervention group
Group type: COMPARATOR
Intervention: T-piece circuit (CPAP0)
Number of subjects: 80
Study 7645695 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 cmH2O of continuous positive airway pressure (CPAP5)
Number of subjects: 80
Study 7645695 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 cmH2O of continuous positive airway pressure (CPAP10)
Number of subjects: 80
Study 2911999 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium phytate (2 mg)
Number of subjects: 0
Study 2911999 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium phytate (25 mg)
Number of subjects: 0
Study 2911999 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium phytate (250 mg)
Number of subjects: 0
Study 2911999 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid
Number of subjects: 0
Study 2911999 — intervention group
Group type: EXPERIMENTAL
Intervention: Meat
Number of subjects: 0
Study 1095159 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized lidocaine
Number of subjects: 10
Study 1095159 — intervention group
Group type: COMPARATOR
Intervention: Control (no nebulized lidocaine)
Number of subjects: 10
Study 31347612 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg lanadelumab every 2 weeks
Number of subjects: 100
Study 31347612 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 27989681 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation (CA) plus antiarrhythmic drugs
Number of subjects: 137
Study 27989681 — intervention group
Group type: COMPARATOR
Intervention: Antiarrhythmic drugs alone (control group)
Number of subjects: 137
Study 25849627 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Inspection with Acetic Acid (VIA)
Number of subjects: 654
Study 25849627 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Inspection with Lugol’s Iodine (VILI)
Number of subjects: 654
Study 25849627 — intervention group
Group type: EXPERIMENTAL
Intervention: VILI among women with CD4+ count < 350
Number of subjects: 654
Study 25849627 — intervention group
Group type: EXPERIMENTAL
Intervention: VIA among women with CD4+ count < 350
Number of subjects: 654